| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 130, 2495-2504, Copyright © 1992 by Endocrine Society
ARTICLES |
Z Schwartz, B Brooks, L Swain, F Del Toro, A Norman and B Boyan
University of Texas Health Science Center, San Antonio 78284-06295.
1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] and 24,25-(OH)2D3 have been shown to promote chondrocyte proliferation and differentiation; resting zone chondrocytes respond primarily to 24,25-(OH)2D3, whereas growth zone chondrocytes respond primarily to 1,25-(OH)2D3. This study determined whether resting zone and growth zone cells produce 24,25- (OH)2D3 or 1,25-(OH)2D3; whether this production is regulated by 1,25- (OH)2D3 (10(-8) M), 24,25-(OH)2D3 (10(-7) M), dexamethasone (10(-7) M), or recombinant human transforming growth factor-beta 1 (11 ng/ml); and whether the metabolites produced are biologically active. Confluent fourth passage rat costochondral growth zone or resting zone chondrocytes were cultured in Dulbecco's Modified Eagle's Medium containing [3H]25-hydroxyvitamin D3 ([3H]25OHD3), 2% fetal bovine serum, and antibiotics. Metabolism of [3H]25OHD3 was measured by analyzing the lipid extracts of the conditioned medium and the cell layer for [3H]1,25OHD3, [3H]1,25-(OH)2D3, and [3H]24,25-(OH)2D3 using flow-through scintillation spectroscopy of HPLC eluates. Chemically synthesized radioinert vitamin D3 metabolites were used as standards, and their migration was determined by absorbance at 254 nm. To ensure that the radioactive peaks were 1,25-(OH)2D3 and 24,25-(OH)2D3, the fractions were rechromatographed into three other HPLC solvent systems. Biological activity was confirmed; the addition of HPLC-purified 1,25- (OH)2D3 produced by growth zone chondrocytes elicited a dose-dependent stimulation of alkaline phosphatase specific activity in growth zone cell cultures, but had no effect on the resting zone cells. There was a time-dependent increase in both [3H]1,25-(OH)2D3 and [3H]24,25-(OH)2D3 in the conditioned medium of both types of cultures. At 24 h, the percent conversion of [3H]25OHD3 to [3H]1,25-(OH)2D3 was 5.3 +/- 1.2, and the percent conversion to [3H]24,25-(OH)2D3 was 1.8 +/- 0.4 in growth zone chondrocyte cultures. No such effect was found in cultures freeze-thawed five times or without cells. When resting zone cells were cultured with [3H]25OHD3, the percent conversion to 1,25-(OH)2D3 and 24,25-(OH)2D3 was 4.5 +/- 1.0 and 1.7 +/- 0.4, respectively. The addition of dexamethasone significantly increased the percent production of 1,25-(OH)2D3 at 6 and 24 h and at 6 h by resting zone and growth zone cells, respectively, compared to the control values. Recombinant human transforming growth factor-beta 1 increased the percent production of 1,25-(OH)2D3 after 1 h in resting zone cells and, after 24 h, the production of 24,25-(OH)2D3 in growth zone cells. Radiolabeled 1,25-(OH)2D3 and 24,25-(OH)2D3 were not detected in the cell layer.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
![]() |
R. Dreier, B. K. Gunther, T. Mainz, I. Nemere, and P. Bruckner Terminal Differentiation of Chick Embryo Chondrocytes Requires Shedding of a Cell Surface Protein That Binds 1,25-Dihydroxyvitamin D3 J. Biol. Chem., January 11, 2008; 283(2): 1104 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Bikle For Whom the Bugs Toll; They Toll for D IBMS BoneKEy, April 1, 2006; 3(4): 12 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Vanhooke, J. M. Prahl, C. Kimmel-Jehan, M. Mendelsohn, E. W. Danielson, K. D. Healy, and H. F. DeLuca CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1{alpha}-hydroxylase promoter activity in the skin PNAS, January 3, 2006; 103(1): 75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Tryfonidou, M. S. Holl, M. Vastenburg, M. A. Oosterlaken-Dijksterhuis, D. H. Birkenhager-Frenkel, W. E. van den Brom, and H. A. W. Hazewinkel Hormonal regulation of calcium homeostasis in two breeds of dogs during growth at different rates J Anim Sci, June 1, 2003; 81(6): 1568 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Schwartz, V. L. Sylvia, D. Larsson, I. Nemere, D. Casasola, D. D. Dean, and B. D. Boyan 1alpha ,25(OH)2D3 Regulates Chondrocyte Matrix Vesicle Protein Kinase C (PKC) Directly via G-protein-dependent Mechanisms and Indirectly via Incorporation of PKC during Matrix Vesicle Biogenesis J. Biol. Chem., March 29, 2002; 277(14): 11828 - 11837. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.D. Boyan, V.L. Sylvia, D.D. Dean, F. Del Toro, and Z. Schwartz DIFFERENTIAL REGULATION OF GROWTH PLATE CHONDROCYTES BY 1{alpha},25-(OH)2D3AND 24R,25-(OH)2D3 INVOLVES CELL-MATURATION-SPECIFIC MEMBRANE-RECEPTOR-ACTIVATED PHOSPHOLIPID METABOLISM Crit. Rev. Oral. Biol. Med., March 1, 2002; 13(2): 143 - 154. [Abstract] [Full Text] |
||||
![]() |
H. Robson, T. Siebler, D. A. Stevens, S. M. Shalet, and G. R. Williams Thyroid Hormone Acts Directly on Growth Plate Chondrocytes to Promote Hypertrophic Differentiation and Inhibit Clonal Expansion and Cell Proliferation Endocrinology, October 1, 2000; 141(10): 3887 - 3897. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Schwartz, V. L. Sylvia, D. D. Dean, and B. D. Boyan The Synergistic Effects of Vitamin D Metabolites and Transforming Growth Factor-{beta} on Costochondral Chondrocytes Are Mediated by Increases in Protein Kinase C Activity Involving Two Separate Pathways Endocrinology, February 1, 1998; 139(2): 534 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-G. Seo, T. A. Einhorn, and A. W. Norman 24R,25-Dihydroxyvitamin D3: An Essential Vitamin D3 Metabolite for Both Normal Bone Integrity and Healing of Tibial Fracture in Chicks Endocrinology, September 1, 1997; 138(9): 3864 - 3872. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Peleg, M. Sastry, E. D. Collins, J. E. Bishop, and A. W. Norman Distinct Conformational Changes Induced by 20-epi Analogues of 1[IMAGE],25-Dihydroxyvitamin D[IMAGE] Are Associated with Enhanced Activation of the Vitamin D Receptor J. Biol. Chem., May 5, 1995; 270(18): 10551 - 10558. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |